Electrocardiogram monitoring joins blood pressure measurement in receiving clearance, making the Galaxy Watch Active2 Samsung’s most informed and convenient health tracker yet Samsung Electronics announced today that the Electrocardiogram (ECG) function of the Samsung Health Monitor app has been cleared by South Korea’s Ministry of Food and Drug Safety (MFDS). The ECG feature uses advanced sensor technology on the Galaxy Watch Active2, and will enable users to measure and analyze their heart rhythm for irregularities indicating Atrial Fibrillation (AFib). AFib is the most common abnormal heart rhythm, affecting an estimated 33.5 million people worldwide, with 5 million new patients diagnosed annually. It can significantly increase the risk of complications, including blood clots, heart failure and stroke. Every year, over 16 million people will develop a stroke, of which AFib and high blood pressure (hypertension), are known to be the leading causes. The Samsung Health...
Comments
Post a Comment